RNA · Atrium Therapeutics, Inc. · Earnings Call Transcripts & Audio
Market Cap
$177.21M
Shares
17.11M
Atrium Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Atrium Therapeutics, Inc. (RNA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q2
2026-08-13
Atrium Therapeutics, Inc. (RNA) Q2 2026 Earnings Call
Revenue
$3.00M
▼ 21.9% YoY Diluted EPS
$-1.18
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
Atrium Therapeutics, Inc. (RNA) Q1 2026 Earnings Call
Revenue
$19.64M
▲ 1148.3% YoY Diluted EPS
$-0.97
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Showing 1–2 of 2 earnings calls
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
64 filings
64 filers
Visit website
Investor relations